Outlines an approach for qualifying the design and manufacture of a heart valve substitute through
risk management. The selection of appropriate qualification tests and methods are derived from the
risk assessment. The tests may include those to assess the physical, chemical, biological, and
mechanical properties of heart valve substitutes and of their materials and components. The tests
may also include those for preclinical in vivo evaluation and clinical evaluation of the finished heart
valve substitute.